Longevity for women
How women age, what menopause changes in bone, heart and brain, and the few moves with real evidence behind them
Updated 40 min read59 sources
The short answer
Women in Germany live 4.6 years longer than men (83.4 versus 78.8 years),[14] but they spend more of those years in poor health, so the real goal is more healthy years, not just more years. The turning point is menopause, at around 51: bone loss at the spine speeds up to about 2.5% a year,[2] heart risk rises, and many women notice changes in memory and concentration. The habits with the most weight behind them are strength training 2 to 3 times a week[31] and about 1.2 g of protein per kg of body weight a day if you train.[16] On the medical side, have an informed talk about hormone replacement therapy (HRT) with a menopause-literate doctor,[5] and choose blood tests by your symptoms and risks rather than as a blanket panel.
This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise routine, or supplement regimen.
Why do women live longer but not healthier?
Women live longer than men but spend more of those extra years with disease and disability, which makes healthy years, not total years, the real target. In Germany the gap is 4.6 years: 83.4 for women and 78.8 for men, according to the Destatis life tables for 2023/25 (as of October 2026).[14] Behind both halves of that picture, the longer life and the sicker stretch near its end, sit a few biological differences.
The first is genetic. Women carry two X chromosomes, so when one copy of a gene has a typo, the other copy can often cover for it. Men, with a single X, have no such backup. That spare copy is part of why women tend to have stronger immune systems and fewer of certain inherited conditions.
A stronger immune system has a price, though. Almost 80% of people with autoimmune disease are women,[55] which means their immune system attacks their own tissue, as in rheumatoid arthritis, lupus or Hashimoto's thyroiditis. These are long-running conditions that eat into exactly the healthy years this guide is about.
The second big difference is estrogen. Before menopause it helps keep cholesterol in a good range, blood vessels flexible and bones dense. When it falls at menopause, much of that protection goes with it. That is why menopause, more than any round birthday, is the point where many women's health risks start to climb, and why most of this guide is built around it.
Those differences also mean that much of the longevity advice you read was not tested on bodies like yours. Many of the studies people quote enrolled mostly men or did not report results by sex. That is slowly changing, and CALERIE, the big calorie-restriction trial, was about 70% female.[6] So before you copy the doses of a protocol, check whether it was tested in women.
Which hormones change in menopause, and what does that mean for HRT?
Estradiol, the body's main estrogen, is the hormone that changes most: it swings unpredictably through perimenopause and then falls steeply once periods stop. Knowing that timeline helps you tell which symptoms belong to which phase, and when a treatment like HRT makes sense. Our guides on perimenopause and hormone replacement therapy go deeper on both.
The timeline
- Perimenopause (usually in your 40s): estrogen and progesterone swing without warning, so periods turn irregular, sleep breaks up, moods shift and hot flashes start. This phase can last 4 to 10 years.
- Menopause (on average around 51): you can only name it looking back, after 12 months in a row without a period. Estradiol ends up at a small fraction of its earlier level, and a weaker estrogen called estrone becomes the main one left.
- Postmenopause: the decades that follow, when low estrogen speeds up bone loss, raises heart risk and shifts your metabolism.
If you are unsure which phase you are in, our menopause test sorts your symptoms.
What the big HRT trials showed
Hormone replacement therapy (HRT) puts back some of that lost estrogen, and few treatments in women's health have swung so far in reputation. The first big results of the Women's Health Initiative (WHI) trials raised alarms about breast cancer and heart risk in 2002.[7] After 18 years of follow-up, though, the trials as a whole came out neutral for deaths from any cause.[1] Women who started in their 50s showed a more favourable trend than women who started in their 70s. That trend comes from a subgroup, though, so it supports an idea rather than proving it.
That idea is the timing hypothesis: started within about 10 years of menopause or before 60, HRT seems to have a better balance of benefit and risk. The major menopause societies, NAMS in North America and the International Menopause Society, still back it.[5, 9] The one trial built to test it, ELITE, used estradiol pills. It found that estradiol slowed the thickening of artery walls only in women who started within 6 years of menopause, not in those 10 or more years out.[8] Artery-wall thickness is an ultrasound marker rather than heart attacks or deaths, so proof on hard outcomes is still missing.
How you take HRT matters more than whether the label says "bioidentical". Estradiol through the skin (a gel or patch) looks easier on blood-clot and stroke risk than estrogen pills. Micronized progesterone, the kind identical to the body's own, also looks gentler on breast tissue than older synthetic progestins such as the one used in WHI.[5, 9] Both findings come from observational studies, which watch people rather than assign treatments, and no trial has yet shown which progestogen is safest for the breast. The benefits for hot flashes, bone and quality of life, by contrast, are well established.[5]
What changed in the US in 2025 and 2026
In November 2025 the US FDA announced it would remove its boxed warnings, the most prominent kind on a US drug label, from menopause hormone therapy.[10] Those warnings covered heart disease, breast cancer and probable dementia,[10] and on 12 February 2026 the FDA approved the new labels for a first six products.[37] The warning about cancer of the uterine lining stays for estrogen taken without a progestogen.[10] All of this is a US label change. In Europe the product information comes from the EMA and national agencies, and it still lists these risks (as of October 2026).
When systemic HRT is usually ruled out
Softer US labels do not change who should not take hormones that reach the whole body. Systemic HRT is usually ruled out if you have.[5, 36]:
- breast cancer now or in the past, or suspected breast cancer
- another hormone-sensitive cancer
- a blood clot now or in the past, or a known clotting disorder
- a past heart attack, coronary heart disease or a stroke
- unexplained vaginal bleeding
- severe liver disease
This list is why the decision belongs with a doctor who does menopause care. Low-dose vaginal estrogen is a separate question. For some cancer survivors whose symptoms do not respond to non-hormonal options, it can be an option after talking to the oncologist[5]
If HRT is not an option
For women on that list, the EU has authorised two prescription non-hormonal medicines for moderate to severe hot flashes: fezolinetant (Veoza).[51] and, since November 2025, elinzanetant (Lynkuet)[52] Fezolinetant needs liver blood tests before you start and monthly for the first three months. It is also not recommended with moderate or severe liver disease, or while you are being treated for breast cancer or another estrogen-dependent cancer.[51] Elinzanetant is also authorised for hot flashes caused by anti-hormone therapy after breast cancer.[52] Ask your gynecologist whether one of them fits you, and ask your insurer whether it pays (as of October 2026).
Thyroid and testosterone
Not every midlife symptom comes from estrogen, though, and the thyroid deserves a look first. Thyroid problems are much more common in women than in men, and an underactive thyroid (hypothyroidism, when the gland makes too little hormone) becomes more common with age. It can look just like menopause or make it worse. If you have tiredness, weight or mood changes, heavy or irregular periods, or thyroid disease in the family, ask for a TSH test, the standard thyroid blood test. Screening women without symptoms is not a guideline recommendation.[46]
Testosterone and DHEA also decline with age in women, but they are a weaker lead. Low levels do not reliably explain symptoms, and there is no validated cut-off for "low testosterone" in women. The only well-supported use of testosterone in women is low sexual desire that causes distress after menopause, assessed by a specialist.[44] Trials do not support it for muscle, energy or mood.[44]
How do women protect bone and muscle?
Women protect bone and muscle best by lifting weights, eating enough protein and calcium, and getting a bone scan at the right time. All three matter because both tissues drain away faster after menopause. Osteoporosis (bones that turn thin and brittle) causes far more fractures in women over 50 than in men. A hip fracture in older age is serious, and a large share of older people die within a year of one.
Women start adult life with less bone than men, and menopause speeds up the loss. The SWAN study followed women through the transition. In the three years around their last period, they lost about 7% of the bone in their lower spine, roughly 2.5% a year.[2] Over ten years the spine was down about 10%.[2] The pace varied from woman to woman, and because women also live longer, the loss has more years to add up.
Training is the base, not the whole fix
Strength training is the most useful habit for muscle, balance and falls, and it slows bone loss as well. Trials in postmenopausal women found small but real gains in bone density, though no proven drop in fractures.[31] Loading a bone signals it to stay strong. The same sessions build the muscle that fights sarcopenia (age-related muscle loss) and train the balance that keeps you from falling. Two to three sessions a week is the range to aim for. If your bone density is already low, though, medication is the stronger tool for preventing fractures, with training as the base under it.[17]
Calcium, vitamin D and K2
Training needs raw material. Over 50, aim for about 1,000 to 1,200 mg of calcium a day, ideally from food.[17] Vitamin D matters most when your skin makes little, as it does in the winter months. For that situation the DGE (the German nutrition society) recommends 800 IU (20 mcg) a day.[23] The US bone guideline suggests a similar 800 to 1,000 IU for adults over 50.[17] The adult upper limit is 4,000 IU a day from food and supplements together, and it is a ceiling, not a target.[17, 26]
With vitamin D, enough does the job, and more adds no benefit. For healthy adults under 75, the 2024 Endocrine Society guideline advises against routine blood tests and against extra vitamin D above the US daily reference intakes.[22] Those intakes are 600 IU a day up to age 70 and 800 IU after. A blood test does make sense if you have bone loss, a risk of deficiency, or take high doses. The two camps read the result differently. The DGE counts 50 nmol/L (20 ng/mL) as adequate,[23] while bone specialists aim for 75 to 125 nmol/L (30 to 50 ng/mL).[17]
Some doctors add vitamin K2, on the idea that it steers calcium into bone rather than arteries. The outcome evidence is mixed, though, and Europe's food-safety authority (EFSA) has rejected K2-specific heart-and-vessel claims twice.[19, 20] Vitamin D in these doses is low-risk for most adults, and K2 is an optional extra to discuss with your doctor. If you take a blood thinner that works by blocking vitamin K, such as phenprocoumon (Marcumar) or warfarin, do not take K2 unless your prescriber agrees. In a trial in volunteers on such a blood thinner, as little as 10 to 20 mcg a day of MK-7, a common form of K2, weakened its effect in some of them.[28]
Muscle: the quieter loss
Muscle follows a similar curve to bone, only with less fuss. Muscle mass starts slipping from around 30, and the loss speeds up after menopause. The fix is the same pair: lift weights and eat enough protein, about 1.2 g per kg of body weight a day if you train.[16]
When to get a bone scan
A DEXA scan (the standard low-dose X-ray for bone density) shows where you stand. The US Preventive Services Task Force (USPSTF), an expert panel that rates screening tests, updated its advice on 14 January 2025.[21]:
- 65 or older: screening for all women (Grade B, meaning it is recommended)[21]
- Postmenopausal and under 65: screening earlier if a short risk calculator such as FRAX, OST or ORAI puts you at higher fracture risk. Risk factors include low body weight, early menopause and a family history of fractures.[21]
- After a fragility fracture, or on long-term steroid tablets: the screening rules do not apply to you.[21] A fragility fracture is a break from a fall at standing height or less, and it can be a reason for treatment on its own, so ask for a bone assessment now.[17]
- Men: too little evidence to recommend for or against screening.[21]
A personal baseline scan early in menopause is a longevity-medicine preference, not standard care. In Germany, statutory health insurance (GKV) usually pays for a DEXA only when there is a specific medical reason. Whatever the result, keeping alcohol low and not smoking protect bone as well. If the scan shows low bone density, ask your doctor about medication such as bisphosphonates.
What makes women's heart risk different?
Heart disease is the leading cause of death in women worldwide, ahead of breast cancer, yet in women it is still missed and undertreated more often than in men. Before menopause, estrogen helps keep cholesterol balanced, vessels flexible and inflammation low, which is why heart attacks in younger women are rare. After menopause the rate of new cases climbs and the gap with men starts to close. Even so, fewer women than men die of heart disease into their 60s and 70s.
Heart-attack symptoms in women
Chest pain, pressure or tightness is still the most common heart-attack symptom in women. But women more often have other symptoms with it, or instead of it: shortness of breath, nausea, pain in the back, jaw or arm, unusual tiredness that can last days, or dizziness.[38] Because that mix does not match the textbook picture, the diagnosis can be delayed. If you think you might be having a heart attack, call 112 straight away, even if you are not sure.
Risk factors that are specific to women or matter more for them
Some heart risk factors only women have, and others weigh more heavily in women:
- Preeclampsia (dangerously high blood pressure in pregnancy) is linked to about twice the later risk of coronary heart disease and stroke, and to a higher risk of heart failure.[3]; a newer analysis puts that heart-failure risk lower than the older one did[4]
- Gestational diabetes (diabetes that first shows up in pregnancy) is linked to about 1.5 times the risk of heart and vessel disease, mostly in women who later develop type 2 diabetes.[18]
- Menopause before 45, especially before 40 (premature).[12]
- Polycystic ovary syndrome (PCOS).
- Autoimmune conditions, which keep inflammation high.
- Depression and chronic stress, both more common in women.
What to do about it
You cannot undo a past pregnancy complication or an early menopause, but you can watch the numbers they push up more closely. The basics are blood pressure, cholesterol and blood sugar. Two extra blood values add detail: Lp(a), a mostly inherited cholesterol particle, and hsCRP, a marker of inflammation. A growing waist, high triglycerides (a type of blood fat) and rising fasting glucose are early signs of metabolic syndrome. That is the name for belly fat, high blood pressure, high blood fats and high blood sugar showing up together. The section on blood tests around 40 explains which of these to ask for.
Alongside the checks, aim for 150 minutes of moderate or 75 minutes of vigorous aerobic exercise a week. Raise heart risk with your doctor at menopause rather than at 65, especially if you had a pregnancy complication.
Why are women more affected by Alzheimer's?
Most people with Alzheimer's are women, partly because women live longer and more of them reach the ages when the disease is common. Newer research suggests that biology plays a part too, and several of those biological threads run through menopause.
The first is fuel. When estrogen falls at menopause, the brain changes how it powers itself, and brain scans show that women's brains use less glucose, their main fuel, during the transition. What that means for Alzheimer's risk is still being researched.
Genes add a second thread. APOE4 is the strongest known genetic risk factor for Alzheimer's. Among people with one copy, women aged 65 to 75 had a higher risk than men of the same age.[45] Across the wider range of 55 to 85, though, the risk was about the same.[45] Mood adds a third thread. Chronic stress and depression are both more common in women, and both are linked to a smaller hippocampus (the brain's memory centre) and a higher dementia risk.
Sleep is the lever you can pull
Menopause and sleep feed each other in a loop: hot flashes break up sleep, and poor sleep makes menopause symptoms feel worse. In animal studies, deep sleep helps the brain flush out waste proteins such as amyloid, through what researchers call the glymphatic system. Whether broken sleep in menopause does the same harm in humans is still being studied. Protecting sleep through the transition is good for the brain either way, and the basics are simple:
- Keep the bedroom cool, around 16 to 18 °C (60 to 65 °F).
- Go to bed and get up at the same times.
- Cut caffeine after noon.
- If hot flashes are wrecking your sleep, talk to your doctor about HRT or a non-hormonal option.
Friends, exercise and hearing
Sleep is not the only habit that counts. Strong social ties are linked to a lower dementia risk in observational studies, and they are good for wellbeing whatever the exact effect. Regular aerobic exercise belongs on the list as well, so the brisk walks and bike rides from the exercise section count twice. The usual advice adds a Mediterranean-style diet with fish, learning new things and keeping stress in check, all habits you build at home rather than in a clinic. Hearing loss deserves a line of its own, because it is one of the few dementia risk factors that is easy to treat. If conversations start to blur, get your hearing checked.
What should women eat for longevity?
For longevity, women should put protein first, at about 1.2 g per kg of body weight if they train.[16] Next come enough calcium and vitamin D for bone, and iron matched to your life stage, since iron needs fall slightly after menopause.[24] What your body needs from food shifts across your life, which is why a one-size plan misses the parts that matter most for women.
Protein: more than the official minimum
The official reference intake for adults is 0.8 g of protein per kg of body weight a day, rising to 1.0 g/kg from 65.[27] Experts on older adults recommend 1.0 to 1.2 g/kg, and 1.2 g/kg or more for people who exercise.[16] So for a woman who lifts weights, about 1.2 g/kg is a sensible target, which comes to about 72 g a day at 60 kg. If you have kidney disease, set your protein target with your doctor first.
Per meal, a rough guide is enough: about 25 to 40 g of protein per main meal is a practical rule of thumb. It is not a hard switch, because muscle building rises with the dose, and in one trial even a 100 g serving kept working for hours.[57] Eggs, dairy, fish, poultry and soy make the target easier to reach, since they are rich in leucine, the amino acid that most strongly signals muscle building. Our protein calculator turns your weight and activity into a daily gram target, per meal and in g/kg.
Iron: the one need that falls
Iron is the nutrient where women's needs drop with age. In Germany and Austria the reference intake for women is 16 mg a day while they still menstruate and 14 mg after menopause.[24] Men need 11 mg (DGE/ÖGE, as of 2025).[24] Switzerland uses its own reference values, and the US figures are lower after menopause (18 and 8 mg). Too much iron drives the kind of cell damage linked to ageing, so after menopause do not take iron supplements unless a blood test shows you are actually low.
Women's iron needs drop after menopause but stay above men's
Reference intake for iron in Germany and Austria, mg a day
That blood test needs more than hemoglobin, because iron deficiency can cause tiredness and poor exercise tolerance before your hemoglobin drops. Ask for three values together: ferritin (your iron stores), transferrin saturation (how much iron is on its way through the blood) and CRP, an inflammation marker. CRP matters because ferritin rises with inflammation and can then look falsely reassuring. Where the ferritin cut-off lies is debated. Many labs treat values below about 15 to 30 ng/mL as deficiency, and some doctors look closer below 50 if you have symptoms.
Your life stage decides which problem is more likely. In late perimenopause, heavy bleeding can empty your stores, while after menopause too much iron is the more common worry. Low iron after menopause is never just a supplement question, though. Without periods, your doctor needs to find where the iron is going, and iron-deficiency anaemia usually means a check of the gut.[47]
Folate
Folate helps your cells build DNA and runs methylation, the small chemical tags that switch genes on and off. Adults need about 300 mcg of folate equivalents a day, ideally from leafy greens, beans, lentils and whole grains.[59] If you take a supplement, methylfolate (L-5-MTHF) and plain folic acid both work. The claim that people with an MTHFR gene variant must avoid folic acid is not backed by the CDC or the major guidelines.
Pregnancy changes the picture, because food alone is then not enough. If you could become pregnant, take 400 mcg of folic acid a day as a supplement on top of a folate-rich diet.[59] Start at least 4 weeks before conception and continue through the first trimester.[59] Folic acid prevents neural tube defects, which are serious birth defects of the brain and spine. If you have had a pregnancy with a neural tube defect, take epilepsy medicines or have diabetes, ask your doctor about a higher dose.
Omega-3: fish first
Omega-3 fats from fish (EPA and DHA) belong in a heart- and brain-friendly diet, and oily fish once or twice a week is the simple default. Capsules have a weaker record than the fish itself. In a large trial in healthy adults, 1 g a day did not lower the combined rate of heart attacks, strokes and heart deaths.[30] In trials of mostly older people, fish-oil supplements were also linked to more atrial fibrillation (an irregular heart rhythm), more so above 1 g a day.[29] If you have a heart-rhythm problem or take blood thinners, talk to your doctor before taking fish oil.
Phytoestrogens
Phytoestrogens are plant compounds, such as the isoflavones in soy and the lignans in flaxseed, that bind weakly to estrogen receptors. They may take the edge off mild menopause symptoms and help bones. Traditional Asian diets high in soy are linked to lower rates of osteoporosis and hot flashes, though genes and a lifetime of eating that way play a part too.
Other nutrients worth knowing
- Calcium and vitamin D: the amounts are in the section on bone and muscle, and the kitchen section turns them into food.
- Vitamin K2: optional, with mixed evidence,[19, 20] and not with Marcumar or warfarin unless your prescriber agrees.[28]
- B12: your gut absorbs less of it as you age, so it is worth testing after 50.
- Magnesium: about 300 mg a day in total for women, mostly from food (DGE).[25] It is involved in muscle, nerve and bone function. If you take a supplement, keep it at or below 250 mg a day on top of food, the upper level EFSA set for magnesium from supplements[26]; with kidney disease, ask your doctor first.
Which exercise matters most for women over 40?
For women over 40, strength training matters most, because it works against muscle loss, falls and bone loss at the same time. Aim for 2 to 3 sessions a week, or up to 4 if you recover well.[31] Pair it with easy aerobic cardio and pelvic floor training, and you cover most of what changes in the body with age.
Strength training comes first
Lifting works best when it is progressive. Use compound lifts that train many muscles at once, such as squats, deadlifts, rows and presses. Then add a little weight over time, because that slow progression is what makes muscle and bone adapt. Heavy weights are nothing to fear: women have far less testosterone than men, so bulking up by accident is not a realistic risk.
If you already have osteoporosis or a spinal fracture, the advice changes a little. Strength and balance work are still recommended, but avoid deep forward bending of the spine under load, and after a vertebral fracture keep impact to about brisk-walking level. Start with a physiotherapist or a trained coach.[32]
Zone 2 cardio
Zone 2 is easy aerobic work at a pace where you can still hold a conversation, such as a brisk walk, cycling or easy swimming. It trains your heart and your mitochondria, the small power plants in your cells, without pounding your joints. That gentle load matters more after menopause, when metabolism tends to slow. The general recommendation is 150 minutes of moderate activity a week. Many coaches aim for 150 to 180 minutes of Zone 2, which is a coaching target rather than a researched dose, and that time counts toward the general recommendation.
Pelvic floor training
Your pelvic floor is the sling of muscles that holds up your bladder, uterus and bowel. When it weakens, urine leaks follow, and they are common in older women. Kegel exercises strengthen it, breathing well and bracing your core while you lift protect it, and a pelvic floor physiotherapist can build you a personal plan.
A sample week
Put together, a week might look like this, as a starting point rather than a prescription:
- 2 to 3 strength sessions (full body, or an upper/lower split)
- 3 to 4 Zone 2 sessions of 40 to 50 minutes
- Pelvic floor exercises every day
- 1 to 2 mobility sessions (yoga, stretching)
- At least 1 rest day
Recovery needs sleep, which menopause often breaks, and enough protein, so a protein-rich meal after training is a sensible habit.
Where do you start?
Start this week with three moves: begin strength training, add protein to every meal and keep a regular sleep schedule. Within a month, get a blood panel matched to your symptoms and risks. At your next doctor's visit, raise HRT, heart risk, your bone scan and breast screening.
This week
- Start strength training, even just bodyweight exercises at home.
- Add a serving of protein to every meal.
- Set a consistent sleep schedule.
Within the first month
- Book a blood panel that fits your symptoms and risks; the section on blood tests at 40 lists what to ask for.
- Ask whether you need vitamin D, especially from autumn to spring.
- Take a brisk 30-minute walk every day (brisk enough that talking takes some effort).
At your next doctor's visit
- Go through your heart risk, especially if you are near or past menopause.
- Ask about HRT if menopause symptoms bother you. You are entitled to an informed conversation, and our HRT guide goes deeper.
- Ask when you need a DEXA bone scan: the USPSTF recommends one from 65, and earlier after menopause if you have risk factors.[21]
- Mention any pregnancy complications such as preeclampsia or gestational diabetes, because they are linked to later heart risk.[3, 18]
- Check that your breast screening is up to date.
Breast screening in DACH
Heart disease kills more women, but breast cancer is the most common cancer in women, and its screening rules differ across the three countries (as of October 2026). In Germany the programme invites women aged 50 to 75 every two years. Since July 2024 it includes women aged 70 to 75, and written invitations for that age group are being rolled out across all federal states during 2026. Until yours arrives, you can book through your Zentrale Stelle, the regional office that sends the invitations.[39] The lower age limit is also moving to 45. The legal basis took effect in March 2026, and health-insurance cover is expected from summer 2027, so until then women aged 45 to 49 pay themselves.[39]
Austria invites women aged 45 to 74, and you can join from 40 or from 75 on request.[40] Swiss programmes are run by the cantons, mostly from 50. If breast cancer runs in your family, or you have been told you have dense breasts, ask for a formal risk assessment. Whether extra ultrasound or MRI helps depends on your overall risk, and for dense breasts alone the evidence is still open.[41] Before starting HRT, make sure your regular screening is up to date.
Markers to track over time
A few numbers are worth repeating over the years, so you see a trend rather than a snapshot:
- Bone density: DEXA from 65, earlier with risk factors; how often to repeat it depends on your result and treatment.[21]
- Heart: blood pressure, cholesterol (LDL, HDL and triglycerides), Lp(a) once, and hsCRP, a marker of inflammation.
- Blood sugar: fasting glucose, HbA1c (your longer-term blood sugar average) and insulin.
- Thyroid and vitamin D: when symptoms or risk factors call for it.[22, 46]
- Hormones: only for a specific question, since your doctor reviews symptoms, bleeding and side effects instead.[43]
- Body composition: muscle mass and waist size.
When to see a specialist
Some questions are better answered by a specialist than by your GP:
- a menopause-trained gynecologist or endocrinologist for hormone care
- a pelvic floor physiotherapist if you deal with leaks
- an endocrinologist if a thyroid problem is suspected
- a cardiologist if you have pregnancy-related risk factors or a family history of heart disease
How do you find a menopause-literate doctor in DACH?
The quickest way to find a menopause-literate doctor in Germany, Austria or Switzerland is to start with the national societies. From there, ask a practice a few direct questions on the phone. Care quality varies a lot, and the right doctor can be the difference between years of brushed-off symptoms and a plan that works.
Germany: ask whether a doctor holds the "Menopause-SpezialistIn (MePaS)" certificate from the Deutsche Menopause Gesellschaft (DMG), the German menopause society. There is no public search, so you have to ask the practice directly. The most specialised doctors are gynecologists with the subspecialty (Schwerpunkt) in hormone and fertility medicine, called Gynäkologische Endokrinologie und Reproduktionsmedizin. Large academic centres such as Charité Berlin, LMU Munich and UKE Hamburg often run dedicated menopause clinics.
Austria: ask your gynecologist directly about their menopause training. The national gynecology society, the Österreichische Gesellschaft für Gynäkologie und Geburtshilfe (ÖGGG), runs a menopause awareness campaign.
Switzerland: ask whether the gynecologist belongs to SGEM, the Swiss specialist society for hormones, contraception and menopause. SGEM publishes guidelines at gynendo.ch but no public doctor list (full name: Schweizerische Gesellschaft für Gynäkologische Endokrinologie, Kontrazeption und Menopause, formerly the Schweizerische Menopausegesellschaft). The general gynecology society SGGG also lists practitioners, and the university hospitals in Zurich, Bern, Geneva and Basel run specialist menopause consultations.
Red flag: a gynecologist who refuses by reflex to discuss HRT at all, quoting WHI 2002, without looking at your age, time since menopause and risk factors. Later analyses of the same trials,[1] and the 2022 position statement of the North American Menopause Society, now The Menopause Society[5] supported HRT for the right patients. That support is strongest when HRT starts within 10 years of the last period or before 60. A "no" can still be right if you have one of the conditions that rule HRT out, listed in the hormones section.
Green flags:
- She knows the difference between estradiol through the skin and estradiol pills.
- She prescribes micronized progesterone (Utrogest, Famenita) without hesitation.
- She is happy to walk you through the timing hypothesis and your personal risks and benefits.
- She asks about symptoms beyond hot flashes: mood, brain fog, joint pain and how you sleep.
What does HRT look like at a DACH pharmacy (products, doses, costs)?
A common first choice for HRT in Germany, Austria and Switzerland is estradiol through the skin (Gynokadin Gel or Estramon patches) plus oral micronized progesterone (Utrogest or Famenita). In Germany, statutory insurance covers it at the normal prescription co-pay. Knowing what standard care looks like at the pharmacy counter lets you check whether your prescription matches current practice. Our HRT guide goes deeper on active ingredients, regimens and risks.
The table shows which product does which job:
| Product | Active ingredient | Route | What it is for |
|---|---|---|---|
| Gynokadin Gel | estradiol | skin gel | systemic HRT |
| Estramon | estradiol | skin patch | systemic HRT |
| Utrogest / Famenita | micronized progesterone | capsule | protects the uterine lining |
| Ovestin / Oekolp | estriol | vaginal cream | local dryness and discomfort |
| Estring | estradiol | vaginal ring | local symptoms |
Products as sold in Germany (as of October 2026).
The bioidentical combination
Estradiol through the skin skips the first pass through the liver, and in observational studies it carries a lower risk of blood clots than estradiol pills. Micronized progesterone, in turn, looks gentler on breast tissue than older synthetic progestins.[5, 9] On breast cancer overall, short-term use barely changes the risk, while longer use of combined HRT may raise it slightly.[5]
How it is usually prescribed
- Perimenopause, uterus intact (sequential): estradiol every day plus progesterone on 12 to 14 days a month, which usually gives a predictable monthly bleed. The German label dose is 200 mg of progesterone at bedtime on those days.[36]
- Postmenopause, 12+ months without a period (continuous combined): estradiol and progesterone both daily, with no scheduled bleed. Many menopause specialists use 100 mg of progesterone every night, which is common practice but not the dose on the German label.
- After a hysterectomy: usually estradiol on its own, with no progesterone. Exception: if you have had endometriosis, guidelines advise against estrogen alone, because it can reactivate leftover disease.[50]
Higher estrogen doses can need more progesterone, so your doctor sets the dose. Utrogest contains ingredients made from soy, so it must not be used with a soy or peanut allergy. It can also make you drowsy, which is why it is taken at bedtime.[36]
Progesterone at HRT doses is not contraception either.[36] You can still get pregnant in perimenopause, so ask whether you still need contraception. One option covers both jobs: a hormonal IUD (a small coil placed in the uterus) with 52 mg of levonorgestrel, such as Mirena. It works as contraception and as the progestogen at the same time. Lower-dose IUDs such as Kyleena or Jaydess do not protect the lining on their own, so you would still need progesterone on top.[58]
What it costs
With a prescription, what you pay depends on the country (as of October 2026).[56]:
| Country | What you pay with a prescription |
|---|---|
| Germany | the normal statutory (GKV) co-pay of €5 to €10 per pack |
| Austria | the prescription fee (Rezeptgebühr) |
| Switzerland | your deductible (Franchise), then a 10% co-payment, or 40% for some medicines |
Compounded hormones and testosterone
Compounded products sit outside that system. They include estradiol or testosterone creams mixed to order at a Rezeptur-Apotheke (a pharmacy that makes up prescriptions itself), and DHEA or pregnenolone ordered through specialist international pharmacies in Germany. You pay for these yourself, costs vary widely, and they are not better than the approved bioidentical products your insurance already covers. Testosterone and DHEA products for women are not approved for this use in Germany. Compounded or imported products are also less controlled for dosing and quality than approved medicines.
Vaginal estrogen for local symptoms
Vaginal estrogen treats local symptoms only: Ovestin cream or Oekolp (both estriol), or the slow-release Estring ring (estradiol). It helps with vaginal dryness, painful sex and recurring urinary tract infections, and very little of it reaches the bloodstream. Because so little reaches the blood, it is a separate decision from systemic HRT, including for some cancer survivors, who make it together with their oncologist[5]
Which blood tests make sense for women around 40?
Around 40, the blood tests worth doing are the ones your symptoms and personal risks point to, rather than a blanket panel. For most women that means a thyroid check, iron stores, cholesterol and blood sugar, with vitamin D and hormone tests kept for specific questions.[22, 43, 46] Many perimenopause symptoms, such as tiredness, brain fog, low mood and weight gain, overlap with thyroid disease, low iron and early metabolic trouble. A targeted panel helps you sort out what is hormonal from what is cheaper to fix, and our perimenopause guide covers the phase itself.
The tests to discuss with your GP (Hausarzt) or gynecologist
- Thyroid (TSH): thyroid problems are common in women and can mimic perimenopause. Ask for TSH, the standard thyroid blood test, if you have tiredness, weight or mood changes, heavy or irregular periods, or thyroid disease in the family; if TSH is off, free T4 (the thyroid hormone itself) is added. Screening women without symptoms is not a guideline recommendation,[46] and in Germany it is then usually self-pay.
- Iron stores (ferritin) and B12: iron deficiency can cause tiredness and poor exercise tolerance before anaemia shows, so check your stores, not just hemoglobin. Ferritin is read together with your blood count, transferrin saturation and CRP, and the nutrition section explains the cut-offs. B12 is worth adding because absorption drops with age.
- Vitamin D (the 25-OH vitamin D test): only if you have bone loss, a risk of deficiency or take high doses, because healthy adults under 75 do not need routine tests.[22] If you do test, the DGE counts 50 nmol/L (20 ng/mL) as adequate,[23] while bone specialists aim for 75 to 125 nmol/L (30 to 50 ng/mL).[17]
- Cholesterol, with Lp(a) once: your standard cholesterol numbers plus a one-time Lp(a). Lp(a) is a cholesterol particle that is mostly inherited and barely changes over your life, and it is a strong independent predictor of heart risk.
- Blood sugar (HbA1c and fasting glucose): HbA1c shows your longer-term blood sugar average, and early insulin resistance in perimenopause is common and easy to miss.
- Blood pressure, waist and resting heart rate: cheap, easy to repeat and useful alongside the lab numbers.
A high Lp(a) needs a word of its own, because no drug that targets Lp(a) has yet been shown to prevent heart attacks. The first large outcome trial reported in September 2026 that its drug lowered Lp(a) but not heart events, with full data still pending.[42] A high value therefore means keeping LDL cholesterol, blood pressure and other risks under tighter control.
Cost is worth checking before the needle goes in. Without a medical reason, several of these tests are usually self-pay in Germany, so ask the practice before the blood draw (as of October 2026).
Hormone tests: for specific questions only
Hormone levels are a poor guide in perimenopause, because they swing hard across the cycle. From 45, menopause is diagnosed from your symptoms and periods, and two common tests are not recommended for that: estradiol, and AMH (anti-Müllerian hormone).[43] AMH estimates your egg reserve, so it belongs to fertility planning rather than to menopause.[43] Between 40 and 45, FSH (the hormone that tells your ovaries to ripen an egg) can help in some women.[43] These tests answer specific questions, such as fertility or suspected early menopause before 45, and a symptom diary often tells your doctor more than a single value.
Which symptom means which next step?
Each common menopause symptom points to its own next step. Hot flashes with poor sleep call for a talk about systemic HRT or a non-hormonal drug, while vaginal dryness alone calls for local estrogen. Mood changes and brain fog call for a thyroid and iron check first, and bone worries for a DEXA scan. Any bleeding after 12 months without a period needs a prompt gynecologist visit. Doctors respond better to a specific cluster of symptoms than to "I don't feel right", so use this as a cheat sheet for your appointment.
Hot flashes and poor sleep: talk about systemic HRT. The timing window, within 10 years of your last period and before 60, is when benefits most clearly outweigh risks for the right patients.[5] Estradiol through the skin plus micronized progesterone is a common combination to start with. If HRT is ruled out for you, ask about the non-hormonal drugs fezolinetant (Veoza) or elinzanetant (Lynkuet).[51, 52]
Vaginal dryness or painful sex, and nothing else: ask about estriol cream (Ovestin) or the Estring ring (estradiol). Very little of either reaches the bloodstream, so the risk profile is very different from systemic HRT. It can be an option even when systemic HRT is not, and cancer survivors decide this with their oncologist.[5]
Mood swings, brain fog, broken sleep: rule out thyroid trouble and low iron first (TSH, ferritin), because they cause the same symptoms and are cheaper to fix. If those come back clean, talk about HRT. Oral progesterone has a sedating effect, which is why it is taken at bedtime.[36]
Worried about bones, or fractures run in the family: ask for a DEXA scan, then go through the basics with your gynecologist or GP. Those basics are calcium from food, vitamin D at around 800 IU a day when your skin makes little,[23] and 2 to 3 strength sessions a week. K2 is optional, and not with Marcumar or warfarin unless your prescriber agrees.[28]
Whether you need medication depends on the scan and your history, and the US and German guidelines decide it differently. The US guideline considers bone drugs in any of these cases.[17]:
- your T-score (your bone density compared with a healthy young adult) is -2.5 or lower
- you have had a hip or spine fracture, whatever your bone density
- you have had a fracture of the upper arm, pelvis or wrist, and your bone density is already low
- you have osteopenia (mildly low bone density) plus a high FRAX score, from a short fracture-risk calculator
Germany's DVO guideline works differently. It estimates your risk of a hip or spine fracture over the next 3 years and treats above set thresholds[48, 49] So osteopenia alone is not a reason for drugs, but osteopenia plus a high risk can be, and strength training helps either way.
Weight gain around menopause: three habits help most.
- Enough protein. Muscle studies often used 1.6 to 2.0 g per kg of body weight a day, above the 1.2 g/kg target in the nutrition section. If you have kidney disease, set your protein target with your doctor first.
- Strength training 2 to 3 times a week.
- Aerobic cardio, at least 150 minutes a week.
Heavy or unpredictable bleeding, or any bleeding after 12 months with no period: this is not a longevity question. Book a gynecologist soon, because bleeding after menopause needs the lining of the uterus checked. On sequential HRT a planned monthly bleed is expected. Bleeding outside that pattern, or bleeding that has not settled after the first few months, goes back to your prescriber.[58]
How do you hit protein and bone targets in a DACH kitchen?
A German, Austrian or Swiss kitchen makes both targets easy: Skyr, eggs, chicken, fish and lentils get you to about 30 g of protein per meal. For calcium, Quark, cheese, sardines and kale cover the 1,000 to 1,200 mg a day.[17] The targets themselves are set in the sections on nutrition and on bone and muscle; this one turns them into food from a DACH supermarket.
Protein per meal
Breakfast is often where women fall short, and these staples make it easy to catch up:
- 150 g Skyr or Magerquark (15 to 17 g protein)
- 3 eggs (18 g)
- 100 g chicken breast (23 g)
- 100 g cooked lentils (9 g, plus fibre)
- 30 g Parmesan or aged Gouda (10 g)
- 100 g Lachs or Hering (salmon or herring, 20 g)
- 200 g tofu (16 g)
Stack two or three of these per meal and you reach 30 g without a spreadsheet. A breakfast of 150 g Skyr, 2 eggs and 30 g of nuts, for example, comes to about 35 g.
Calcium: 1,000 to 1,200 mg a day
Food comes first, and dairy does most of the work: Quark, Skyr, plain yogurt, Emmentaler, Gouda and Parmesan. Sardines with the bones, sesame (tahini), Grünkohl (kale), broccoli and fortified plant milks add more. Together, 200 g Skyr, 40 g Emmentaler and a portion of Grünkohl cover roughly a day's worth. If food does not get you there, a supplement closes the gap.
Magnesium: about 300 mg a day
The DGE target for women is about 300 mg of magnesium a day.[25] The easy sources are pumpkin seeds, sunflower seeds, Vollkornbrot (whole-grain bread), Haferflocken (oats), dark chocolate (70%+), spinach and almonds. A small handful of pumpkin seeds plus mostly whole-grain bread usually does it. If you supplement, keep it at or below 250 mg a day on top of food,[26] and if you have kidney disease, ask your doctor first.
Vitamin D and K2
Vitamin D is the one target food alone rarely covers, because in the winter months your skin makes little or none at DACH latitudes. For that situation the DGE recommends 800 IU (20 mcg) a day,[23] and the section on bone and muscle explains when a blood test makes sense. K2 is optional, since EFSA rejected its heart-and-vessel claims.[19, 20] If you take phenprocoumon (Marcumar) or warfarin, do not take K2 unless your prescriber agrees.[28]
Do GLP-1 drugs interact with HRT or the pill?
GLP-1 drugs, the weight-loss and diabetes medicines such as tirzepatide and semaglutide, can interact with hormones you swallow, such as the pill. Estradiol through a patch or gel is not affected. The reason is the stomach: these drugs slow how fast it empties, most of all at the start and after each dose increase. That can lower how much of some oral medicines reaches the blood, which has been shown for the pill but not studied for oral estradiol.[33] Our GLP-1 guide covers prescribing in DACH.
For the pill, tirzepatide and semaglutide behave differently. Tirzepatide (Mounjaro) lowers how much of the pill reaches the blood after the first dose. The US label therefore advises switching to a non-oral method, or adding a barrier method such as condoms, for 4 weeks after starting and after each dose increase.[34] The EU product information, which applies in Germany and Austria, calls the drop not clinically relevant and asks for no adjustment.[33] Many gynecologists still suggest the 4-week backup as a precaution.
Semaglutide (Ozempic, Wegovy) did not change pill hormone levels to a relevant degree.[35] Both tirzepatide labels also recommend contraception for women who could become pregnant while taking it,[33, 34] and that still includes many women in perimenopause.
What this means in practice
- Estradiol through the skin is not affected by slower stomach emptying, so Gynokadin Gel, Estramon patches and Estreva work the same on a GLP-1 drug as off it.
- Oral micronized progesterone (Utrogest, Famenita) has not been studied with these drugs. Lower absorption is plausible, because they slow stomach emptying most at the start and after each dose increase.[33] That matters because progesterone is there to protect the lining of your uterus, and too little would not necessarily show up as symptoms. A 52 mg levonorgestrel IUD (such as Mirena) can take over that job for up to 5 years, but lower-dose IUDs (such as Kyleena or Jaydess) cannot,[58] and any unexpected bleeding needs a check.
- The combined pill on tirzepatide: consider a hormonal IUD or a skin patch, or add a barrier method for 4 weeks after starting and after each dose increase.[34]
So before you start a GLP-1 drug, and again before each dose increase, ask your gynecologist to review your progesterone and contraception plan.
Frequently asked questions
Do women age differently than men?
Does HRT help women live longer?
What is the best exercise for women over 40?
How does menopause affect aging?
What supplements should women take for longevity?
Why do women live longer than men?
Does a late menopause mean you live longer?
Can menopause start at 40?
Does HRT make you gain weight?
How much protein do women need in menopause?
Is HRT safe if I have had a blood clot or take a blood thinner?
Are there non-hormonal treatments for hot flashes?
Do I still need contraception in perimenopause if I take HRT?
Sources59
- Manson JE, Aragaki AK, Rossouw JE, et al. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: WHI Randomized Trials. JAMAdoi:10.1001/jama.2017.11217
- Greendale GA, Sowers M, Han W, et al. (2012). Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). Journal of Bone and Mineral Researchdoi:10.1002/jbmr.534
- Wu P, Haththotuwa R, Kwok CS, et al. (2017). Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomesdoi:10.1161/CIRCOUTCOMES.116.003497
- Inversetti A, Pivato CA, Cristodoro M, et al. (2024). Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. European Heart Journal - Quality of Care and Clinical Outcomesdoi:10.1093/ehjqcco/qcad065
- NAMS Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopausedoi:10.1097/GME.0000000000002028
- Kraus WE, Bhapkar M, Huffman KM, et al. (2019). 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. The Lancet Diabetes & Endocrinologydoi:10.1016/S2213-8587(19)30151-2
- Rossouw JE, Anderson GL, Prentice RL, et al. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: WHI. JAMAdoi:10.1001/jama.288.3.321
- Hodis HN, Mack WJ, Henderson VW, et al. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE). New England Journal of Medicinedoi:10.1056/NEJMoa1505241
- Panay N, Ang SB, Cheshire R, Goldstein SR, Maki P, Nappi RE. (2024). Menopause and MHT in 2024: addressing the key controversies: an International Menopause Society White Paper. Climactericdoi:10.1080/13697137.2024.2394950
- U.S. Food and Drug Administration. (2025). HHS Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement Therapyfda.gov
- Shadyab AH, Macera CA, Shaffer RA, et al. (2017). Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative. Menopausedoi:10.1097/GME.0000000000000710
- Muka T, Oliver-Williams C, Kunutsor S, et al. (2016). Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiologydoi:10.1001/jamacardio.2016.2415
- Collaborative Group on Hormonal Factors in Breast Cancer. (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncologydoi:10.1016/S1470-2045(12)70425-4
- Statistisches Bundesamt (Destatis). (2026). Sterbefälle und Lebenserwartung: Lebenserwartung bei Geburt, Sterbetafel 2023/2025destatis.de
- Norman RJ, Flight IH, Rees MC. (2000). Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD001018
- Bauer J, Biolo G, Cederholm T, et al. (2013). Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. Journal of the American Medical Directors Associationdoi:10.1016/j.jamda.2013.05.021
- LeBoff MS, Greenspan SL, Insogna KL, et al. (2022). The clinician's guide to prevention and treatment of osteoporosis. Osteoporosis Internationaldoi:10.1007/s00198-021-05900-y
- Xie W, Wang Y, Xiao S, et al. (2022). Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis. BMJdoi:10.1136/bmj-2022-070244
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2012). Scientific Opinion on the substantiation of a health claim related to vitamin K2 and contribution to the normal function of the heart and blood vessels (ID 125, further assessment). EFSA Journaldoi:10.2903/j.efsa.2012.2714
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). (2020). MenaQ7 and maintenance of the elastic properties of the arteries: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journaldoi:10.2903/j.efsa.2020.5949
- US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. (2025). Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMAdoi:10.1001/jama.2024.27154
- Demay MB, Pittas AG, Bikle DD, et al. (2024). Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolismdoi:10.1210/clinem/dgae290
- Deutsche Gesellschaft für Ernährung (DGE). (2026). Referenzwerte: Vitamin Ddge.de
- Deutsche Gesellschaft für Ernährung (DGE). (2026). Referenzwerte: Eisen (Ableitung 2023)dge.de
- Deutsche Gesellschaft für Ernährung (DGE). (2026). Referenzwerte: Magnesiumdge.de
- European Food Safety Authority (EFSA). Overview on Tolerable Upper Intake Levels as derived by the Scientific Committee on Food (SCF) and the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)efsa.europa.eu
- Deutsche Gesellschaft für Ernährung (DGE). (2026). Referenzwerte: Proteindge.de
- Theuwissen E, Teunissen KJ, Spronk HM, et al. (2013). Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. Journal of Thrombosis and Haemostasisdoi:10.1111/jth.12203
- Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. (2021). Effect of Long-Term Marine ω-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulationdoi:10.1161/CIRCULATIONAHA.121.055654
- Manson JE, Cook NR, Lee IM, et al. (2019). Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. New England Journal of Medicinedoi:10.1056/NEJMoa1811403
- Howe TE, Shea B, Dawson LJ, et al. (2011). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD000333.pub2
- Brooke-Wavell K, Skelton DA, Barker KL, et al. (2022). Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis. British Journal of Sports Medicinedoi:10.1136/bjsports-2021-104634
- European Medicines Agency. (2026). Mounjaro (tirzepatide): EPAR, product information (SmPC)ema.europa.eu
- U.S. Food and Drug Administration / Eli Lilly. (2026). MOUNJARO (tirzepatide) injection: prescribing information (DailyMed)dailymed.nlm.nih.gov
- European Medicines Agency. (2026). Wegovy (semaglutide): EPAR, product information (SmPC)ema.europa.eu
- Besins Healthcare. (2026). Fachinformation Utrogest 100 mg / 200 mg Weichkapselnfachinfo.de
- U.S. Food and Drug Administration. (2026). FDA Approves Labeling Changes for Menopausal Hormone Therapy Products (press announcement, 12 February 2026)fda.gov
- National Heart, Lung, and Blood Institute (NHLBI). Heart Attack: Symptomsnhlbi.nih.gov
- Bundesministerium für Gesundheit. (2026). Mammographie-Screeningbundesgesundheitsministerium.de
- Öffentliches Gesundheitsportal Österreichs (gesundheit.gv.at). Brustkrebs: Früherkennunggesundheit.gv.at
- US Preventive Services Task Force. (2024). Breast Cancer: Screening (final recommendation)uspreventiveservicestaskforce.org
- Sabouret P, Giamundo DM, Asher E, et al. (2026). Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes. American Journal of Medicinedoi:10.1016/j.amjmed.2026.10.005
- National Institute for Health and Care Excellence (NICE). (2024). Menopause: identification and management (NG23), recommendations 1.3nice.org.uk
- Davis SR, Baber R, Panay N, et al. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolismdoi:10.1210/jc.2019-01603
- Neu SC, Pa J, Kukull W, et al. (2017). Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurologydoi:10.1001/jamaneurol.2017.2188
- US Preventive Services Task Force. (2015). Thyroid Dysfunction: Screening (I statement)uspreventiveservicestaskforce.org
- Ko CW, Siddique SM, Patel A, et al. (2020). AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia. Gastroenterologydoi:10.1053/j.gastro.2020.06.046
- Dachverband Osteologie (DVO). (2023). Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern ab dem 50. Lebensjahr (S3-Leitlinie, 2023; Gültigkeit verlängert bis 31.03.2027)leitlinien.dv-osteologie.org
- Stumpf U, Schmidmaier R. (2024). Sekundäre Frakturprävention/Update Leitlinie Osteoporose 2023 des Dachverbandes Osteologie. Unfallchirurgie (Heidelberg)doi:10.1007/s00113-024-01415-3
- Becker CM, Bokor A, Heikinheimo O, et al. (2022). ESHRE guideline: endometriosis. Human Reproduction Opendoi:10.1093/hropen/hoac009
- European Medicines Agency. (2026). Veoza (fezolinetant): EPAR and product informationema.europa.eu
- European Medicines Agency. (2025). Lynkuet (elinzanetant): EPARema.europa.eu
- Moel M, Harinath G, Lee V, et al. (2025). Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY)doi:10.18632/aging.206235
- Farr JN, Atkinson EJ, Achenbach SJ, et al. (2024). Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature Medicinedoi:10.1038/s41591-024-03096-2
- Fairweather D, Frisancho-Kiss S, Rose NR. (2008). Sex Differences in Autoimmune Disease from a Pathological Perspective. American Journal of Pathologydoi:10.2353/ajpath.2008.071008
- Bundesamt für Gesundheit (BAG). (2026). Differenzierter Selbstbehalt bei Arzneimittelnbag.admin.ch
- Trommelen J, van Lieshout GAA, Nyakayiru J, et al. (2023). The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans. Cell Reports Medicinedoi:10.1016/j.xcrm.2023.101324
- Hamoda H; British Menopause Society. (2023). Progestogens and endometrial protection (BMS Tool for Clinicians, reviewed February 2026)thebms.org.uk
- Deutsche Gesellschaft für Ernährung (DGE). (2026). Referenzwerte: Folatdge.de
Curious about your biological age?
Take our free AI-powered photo test to estimate your visible facial age from facial markers. It's a rough proxy for how your lifestyle is showing up in your skin. True biological age is measured at the cellular level (epigenetic clocks, blood biomarkers) and can't be read from a photo, so treat this as a quick snapshot, not a clinical readout.
Try Free Face AgeExperts in this field
Speakers from the Longevity Cities community on this topic
Related guides
- Biological vs chronological ageWhy your biological age matters more than your birthday
- Longevity supplementsWhat the science really says about NMN, Vitamin D, Omega-3, and more.
- Exercise for longevityThe best types and amounts of exercise for a longer life.
- Creatine for womenStrength, brain, and the menopause transition. What the RCTs really show for women, plus honest myth-busting on kidneys and bloating.
- Menopause symptoms: The complete hubHot flushes, weight, brain fog, joints, sleep and skin. What is really behind the symptoms and what actually helps, honestly framed.
- Stop skin agingSugar, collagen, sun protection and menopause. What keeps skin visibly younger, based on what the dermatology evidence actually shows.
Created by Maurice Lichtenberg, Founder, Longevity Cities
The information provided here is for educational purposes only. Longevity Cities does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
